Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News

Pharma News

FDA Approves Trogarzo

FDA Approves Trogarzo

March 7, 2018 -- Today, the U.

Endocrinology Drugs Market in-Depth Analysis including key players Novo Nordisk, Sanofi, Merck

Endocrinology Drugs Market in-Depth Analysis including key players Novo Nordisk, Sanofi, Merck

HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Endocrinology Drugs market.

Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage

Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage

PARIS (Reuters) - Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health sc...

Europe's medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug

Europe's medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug

(Reuters) - Europe’s medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc’s multiple sclerosis drug Zinbryta, following 12 reports of inflammati...

FDA approves first direct-to-consumer test for breast cancer risk

FDA approves first direct-to-consumer test for breast cancer risk

Federal regulators approved the first direct-to-consumer test for the BRCA genes, which increase the risk of breast and ovarian cancer, the agency announced on Tuesday.

Prescription opioids fail rigorous new test for chronic pain

Prescription opioids fail rigorous new test for chronic pain

СHICAGO — A yearlong study offers rigorous new evidence against using prescription opioids for chronic pain.

Diabetes should be grouped into five types, rather than two, to tailor early treatment, researchers say

Diabetes should be grouped into five types, rather than two, to tailor early treatment, researchers say

Cluster analysis of data from patient groups reveals that diabetes is more complex than the currently identified type 1 and type 2 diabetes.

Experimental HIV antibody successfully suppresses virus for six months: Study

Experimental HIV antibody successfully suppresses virus for six months: Study

An experimental HIV antibody has successfully suppressed the deadly virus for six months without additional treatment, a trial in monkeys has found.

Clearside Biomedical Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of CLS-TA in Macular Edema Associated with Non-Infectious Uveitis

Clearside Biomedical Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of CLS-TA in Macular Edema Associated with Non-Infectious Uveitis

ALPHARETTA, Ga.

Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH

Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH

Pratteln, Switzerland, March 5, 2018 - Santhera Pharmaceuticals (SIX.

Mylan to launch 2 HIV treatments

Mylan to launch 2 HIV treatments

Mylan will soon be bringing its recently approved HIV medications Symfi Lo and Cimduo to market.

Management Board initiates building approval process for EMA premises in Amsterdam

Management Board initiates building approval process for EMA premises in Amsterdam

The European Medicines Agency’s (EMA) Management Board met today in an extraordinary session to further discuss the building approval process for EMA’s future premises in Amsterdam, the Ne...

478 479 480 481482483 484 485 486